Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 34,650
-950 (-2.67%)
At close: Mar 20, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 525.92 billion as of March 20, 2026. Its market cap has increased by 357.88% in one year.
Market Cap
525.92B
Enterprise Value
502.79B
Revenue
3.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
34,650.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has increased from 177.50B to 525.92B, an increase of 196.30%. That is a compound annual growth rate of 60.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 525.92B | 51.31% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 1.06T |
| HansBiomed | 794.36B |
| IntoCell | 714.57B |
| Curocell | 669.44B |
| S.Biomedics | 408.09B |
| curacle co.,ltd. | 379.42B |
| NIBEC | 336.43B |
| Bio Solution | 307.96B |